We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Yeti Holdings
YETI
$3.87B
| $354K | ﹤0.01% |
+8,300
| New | +$249K |
|
1477
C&F Financial
CFFI
$255M
| $352K | ﹤0.01% |
10,600
+900
| +9% | +$30.9K |
|
1478
HP
HPQ
$24.1B
| $351K | ﹤0.01% |
20,182
-598,262
| -97% | -$9.5M |
|
1479
Quince Therapeutics
QNCX
$17.8M
| $351K | ﹤0.01% |
38
+34
| +850% | +$312K |
|
1480
Quad
QUAD
$443M
| $351K | ﹤0.01% |
108,200
+8,900
| +9% | +$27.3K |
|
1481
Walker & Dunlop
WD
$1.67B
| $350K | ﹤0.01% |
6,900
-7,500
| -52% | -$307K |
|
1482
Protagonist Therapeutics
PTGX
$8.8B
| $349K | ﹤0.01% |
19,800
+2,200
| +13% | +$27.6K |
|
1483
ACI Worldwide
ACIW
$5.9B
| $345K | ﹤0.01% |
12,800
-2,700
| -17% | -$70.6K |
|
1484
Hamilton Beach Brands
HBB
$300M
| $341K | ﹤0.01% |
28,700
+2,400
| +9% | +$26.3K |
|
1485
Huntington Ingalls Industries
HII
$11.3B
| $340K | ﹤0.01% |
1,953
-1,579
| -45% | -$293K |
|
|
MCHB
1486
Mechanics Bancorp
MCHB
$3.46B
| $339K | ﹤0.01% |
13,800
+1,100
| +9% | +$25.6K |
|
1487
Shore Bancshares
SHBI
$799M
| $338K | ﹤0.01% |
30,500
+2,500
| +9% | +$24.5K |
|
1488
Timberland Bancorp
TSBK
$342M
| $338K | ﹤0.01% |
18,600
+1,500
| +9% | +$26.1K |
|
1489
Zurn Elkay Water Solutions
ZWS
$8.09B
| $338K | ﹤0.01% |
24,082
-2,491
| -9% | -$32.7K |
|
1490
Genesco
GCO
$412M
| $335K | ﹤0.01% |
15,500
+700
| +5% | +$12.9K |
|
1491
Ambarella
AMBA
$2.88B
| $334K | ﹤0.01% |
7,300
+600
| +9% | +$30.9K |
|
1492
Valley National Bancorp
VLY
$7.93B
| $333K | ﹤0.01% |
42,700
-8,500
| -17% | -$65.2K |
|
|
ITI
1493
DELISTED
Iteris, Inc.
ITI
| $333K | ﹤0.01% |
70,200
-19,400
| -22% | -$80.9K |
|
|
BCPC
1494
Balchem Corp
BCPC
$5.29B
| $332K | ﹤0.01% |
3,500
-1,000
| -22% | -$93.5K |
|
|
KNL
1495
DELISTED
Knoll, Inc.
KNL
| $332K | ﹤0.01% |
27,300
-23,000
| -46% | -$253K |
|
|
TCS
1496
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $331K | ﹤0.01% |
6,820
+567
| +9% | +$21.9K |
|
1497
Box
BOX
$4.24B
| $330K | ﹤0.01% |
+15,900
| New | +$279K |
|
1498
Macy's
M
$6.52B
| $329K | ﹤0.01% |
47,959
+11,259
| +31% | +$69.3K |
|
1499
Arcus Biosciences
RCUS
$3.54B
| $329K | ﹤0.01% |
+13,300
| New | +$359K |
|
1500
Park-Ohio Holdings
PKOH
$551M
| $328K | ﹤0.01% |
19,800
+1,600
| +9% | +$25.1K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.